Section 1 Short title
This Act may be cited as the “Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014”.
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014
AN ACT
To amend the Public Health Service Act relating to Federal research on muscular dystrophy, and for other purposes.
Sec. 2 Initiative through the Director of the National Institutes of Health
Section 404E of the Public Health Service Act (42 U.S.C. 283g) is amended—
in subsection (a)(1)—
by striking “Muscoskeletal” and inserting “Musculoskeletal”; and
by inserting “Becker, congenital muscular dystrophy, limb-girdle muscular dystrophy,” after “Duchenne,”;
in subsection (b)—
in paragraph (2)—
by striking “genetics,” at the second place it appears; and
by inserting “cardiac and pulmonary function, and” after “imaging,”; and
in paragraph (3), by inserting “and sharing of data” after “regular communication”;
in subsection (d)—
in paragraph (2)—
in the matter preceding subparagraph (A), by striking “15” and inserting “18”; and
in subparagraph (A)—
by striking “and the Food and Drug Administration” and inserting “, the Food and Drug Administration, and the Administration for Community Living”;
by inserting “and adults” after “children”; and
by striking “such as the Department of Education” and inserting “including the Department of Education and the Social Security Administration”; and
in paragraph (4)(B), by inserting “, but shall meet no fewer than two times per calendar year” before the period; and
in subsection (e)—
in paragraph (1)—
in the matter preceding subparagraph (A), by striking “through the national research institutes” and inserting “through the agencies represented on the Coordinating Committee pursuant to subsection (d)(2)(A)”; and
in subparagraph (A)—
by inserting “public services,” before “and rehabilitative issues”; and
by inserting “, studies to demonstrate the cost-effectiveness of providing independent living resources and support to patients with various forms of muscular dystrophy, and studies to determine optimal clinical care interventions for adults with various forms of muscular dystrophy” after “including studies of the impact of such diseases in rural and underserved communities”; and
in paragraph (2)(D), by inserting after “including new biological agents” the following: “and new clinical interventions to improve the health of those with muscular dystrophy”.
Sec. 3 Surveillance and research regarding muscular dystrophy
The second sentence of section 317Q(b) of the Public Health Service Act (42 U.S.C. 247b–18(b)) is amended by inserting before the period the following: “and, to the extent possible, ensure that data be representative of all affected populations and shared in a timely manner”.
Sec. 4 Information and education
Section 5(c) of the Muscular Dystrophy Community Assistance, Research and Education Amendments of 2001 (42 U.S.C. 247b–19(c)) is amended—
in paragraph (2)—
by inserting “for pediatric and adult patients, including acute care considerations,” after “issuance of care considerations”;
by inserting “various” before “other forms of muscular dystrophy”; and
by striking “and” at the end;
by redesignating paragraph (3) as paragraph (4);
by inserting after paragraph (2) the following:
“(3) in developing and updating care considerations under paragraph (2), incorporate strategies specifically responding to the findings of the national transitions survey of minority, young adult, and adult communities of muscular dystrophy patients; and”
in paragraph (4), as redesignated, by inserting “various” before “other forms of muscular dystrophy”.